TesoRx Pharma LLC:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:TesoRx Pharma LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11224
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
TesoRx Pharma LLC (TesoRx) is a pharmaceutical company that develops treatments to address unmet medical needs. The company’s product pipeline comprises TSD-001, TSD-005, TSX-011 and TSX-002. Its TSD-001is an intravesical paclitaxel for the treatment of non-muscle invasive bladder cancer. TesoRx develops products based on its novel and proprietary formulation platform, which enables drug delivery by different mechanisms or routes of administration. The company offers products for urology, oncology, and rare diseases. It partners with specialized consultants and research organizations for research and development activities. TesoRx is headquartered in Pomona, California, the US.

TesoRx Pharma LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
TesoRx Pharma LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
TesoRx Pharma LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
TesoRx Pharma LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
TesoRx Pharma LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
TesoRx Pharma LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
TesoRx Pharma LLC, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
TesoRx Pharma Raises USD0.7 Million in Venture Financing 10
TesoRx Pharma Raises USD10 Million in Series B-1 Financing 11
TesoRx Pharma Raises US$4 Million In Venture Financing 12
TesoRx Pharma Raises US$6 Million In Venture Financing 13
Partnerships 14
TesoRx And CoreRx Form Joint Venture For Oral Testosterone Drug 14
Licensing Agreements 15
ASKA Pharma Expands Licensing Agreement with TesoRx Pharma 15
TesoRx Pharma Enters into Licensing Agreement with Aspen Global 16
TesoRx Pharma LLC – Key Competitors 17
TesoRx Pharma LLC – Key Employees 18
TesoRx Pharma LLC – Locations And Subsidiaries 19
Head Office 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
TesoRx Pharma LLC, Pharmaceuticals & Healthcare, Key Facts 2
TesoRx Pharma LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
TesoRx Pharma LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
TesoRx Pharma LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
TesoRx Pharma LLC, Deals By Therapy Area, 2012 to YTD 2018 8
TesoRx Pharma LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
TesoRx Pharma Raises USD0.7 Million in Venture Financing 10
TesoRx Pharma Raises USD10 Million in Series B-1 Financing 11
TesoRx Pharma Raises US$4 Million In Venture Financing 12
TesoRx Pharma Raises US$6 Million In Venture Financing 13
TesoRx And CoreRx Form Joint Venture For Oral Testosterone Drug 14
ASKA Pharma Expands Licensing Agreement with TesoRx Pharma 15
TesoRx Pharma Enters into Licensing Agreement with Aspen Global 16
TesoRx Pharma LLC, Key Competitors 17
TesoRx Pharma LLC, Key Employees 18

List of Figures
TesoRx Pharma LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
TesoRx Pharma LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
TesoRx Pharma LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
TesoRx Pharma LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
TesoRx Pharma LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
TesoRx Pharma LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
TesoRx Pharma LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
TesoRx Pharma LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[TesoRx Pharma LLC:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Anglo Pacific Group plc:企業のM&A・事業提携・投資動向
    Anglo Pacific Group plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Anglo Pacific Group plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Live Nation Entertainment, Inc.:企業のM&A・事業提携・投資動向
    Live Nation Entertainment, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Live Nation Entertainment, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • Therapix Biosciences Ltd (TRPX):製薬・医療:M&Aディール及び事業提携情報
    Summary Therapix Biosciences Ltd (Therapix), formerly Nasvax Ltd is a clinical stage biopharmaceutical company that focuses on the development of cannabinoid based pharmaceuticals for the treatment of central nervous system disorders. Therapix’s major product candidates include THX-110, for the trea …
  • Burlington Northern Santa Fe, LLC:企業の戦略・SWOT・財務情報
    Burlington Northern Santa Fe, LLC - Strategy, SWOT and Corporate Finance Report Summary Burlington Northern Santa Fe, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • FunPep Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary FunPep Co Ltd (FunPep) is a biotechnology venture company that focuses on the development of peptides. The company’s pipeline products include SR-0379 functional peptide and FPP003 antibody inducing peptide. It uses smart peptide research integrated technology for developing functional pepti …
  • Texas Health Resources:企業の戦略的SWOT分析
    Texas Health Resources - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Wheelock and Company Limited :企業の戦略・SWOT・財務情報
    Wheelock and Company Limited - Strategy, SWOT and Corporate Finance Report Summary Wheelock and Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Cryptzone AB:企業の戦略的SWOT分析
    Cryptzone AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Revolution Lighting Technologies Inc (RVLT):電力:M&Aディール及び事業提携情報
    Summary Revolution Lighting Technologies Inc (Revolution) is a lighting company that designs, manufactures, markets and sells light-emitting diode (LED) lighting products. The company's comprehensive products portfolio includes signage, media and accent lighting, interior and exterior LED lamps and …
  • Asian Paints Ltd (ASIANPAINT):企業の財務・戦略的SWOT分析
    Asian Paints Ltd (ASIANPAINT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • EWA Government Systems, Inc.:企業の戦略・SWOT・財務情報
    EWA Government Systems, Inc. - Strategy, SWOT and Corporate Finance Report Summary EWA Government Systems, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Clark Construction Group LLC:企業の戦略的SWOT分析
    Clark Construction Group LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • The Credit Mutuel-Cic Group:企業の戦略・SWOT・財務分析
    The Credit Mutuel-Cic Group - Strategy, SWOT and Corporate Finance Report Summary The Credit Mutuel-Cic Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Visterra Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Visterra Inc (Visterra), formerly Parasol Therapeutics Inc is a clinical-stage biopharmaceutical company that develops antibody therapies for the treatment of infectious diseases. The company develops precision antibody-based biological medicines for infectious and non-infectious diseases. I …
  • Hitachi Ltd (6501):企業の財務・戦略的SWOT分析
    Hitachi Ltd (6501) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Valensa International LLC:企業の戦略・SWOT・財務情報
    Valensa International LLC - Strategy, SWOT and Corporate Finance Report Summary Valensa International LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • ArQule Inc (ARQL):製薬・医療:M&Aディール及び事業提携情報
    Summary ArQule Inc (ArQule) is a development stage clinical biotechnology company. It carries out discovery and development of next-generation, small molecule therapeutics for the treatment of various types of cancer. ArQule develops its oncology product candidates through novel approaches including …
  • Agfa-Gevaert N.V. (AGFB):企業の財務・戦略的SWOT分析
    Agfa-Gevaert N.V. (AGFB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Arena Pharmaceuticals Inc (ARNA)-製薬・医療分野:企業M&A・提携分析
    Summary Arena Pharmaceuticals Inc (Arena) is a biopharmaceutical company which discovers, develops and commercializes small molecule drugs in multiple therapy areas. Its pipeline portfolio encompasses etrasimod for multiple inflammatory indications; ralinepag for the treatment of pulmonary arterial …
  • SteadyMed Therapeutics Inc:製品パイプライン分析
    Summary SteadyMed Therapeutics Inc (SteadyMed), a subsidiary of SteadyMed Ltd is a pharmaceutical company that develops and commercializes therapeutic product candidates. The company provides patchpump, a customizable, pre-filled, and pre-programmed disposable parenteral delivery platform for large …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆